This lecture was supported by Grant Number 6H79FG000999-01M001 from SAMHSA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of SAMHSA. 

About The Speaker

Dr. Schechter is the Chair of the Department of Psychiatry at North Shore Medical Center.  He is a part-time Instructor in Psychiatry at Harvard Medical School and an adjunct Instructor in Psychiatry at Tufts Medical School. Dr. Schechter is a psychoanalyst and a member of the Boston Psychoanalytic Society and Institute. He is a member of the Boston Suicide Study Group, a group of analysts who publish and teach about psychotherapy with suicidal patients. Dr. Schechter has authored multiple papers and book chapters about various aspects of suicide prevention, including clinical evaluation, psychotherapy with suicidal patients, and the therapeutic alliance. He teaches about suicide in the MGH/McLean residency program and at the Boston Psychoanalytic Society and Institute and has lectured nationally and internationally on the topics of suicide risk assessment, psychotherapy with suicidal patients, risk management, and the role of psychopharmacology in suicide prevention.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Mark Schechter, MD, reports as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months.  He will not discuss products, services or off label uses in this presentation. This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on May 13, 2024. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.